Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company developing and delivering innovative therapies in critical care and infectious disease.  Our approved treatments are indicated for use in life-threatening circumstances for seriously ill patients, and our investigational therapies are in development for patients fighting drug-resistant pathogens.

Growing antimicrobial resistance to existing therapies represents an urgent threat to global public health, and is directly related to significant mortality rates and longer, more expensive hospital stays. We are proud to work with physicians, nurses, hospital pharmacists and administrators, and all who devote their time to caring for patients. 

Biotechnology

Health Care

Therapeutics

Innoviva Specialty Therapeutics, Inc.

Steve Basso

David Altarac

Marianne Zhen

Marcie Cain

The Clinical Operations & Development team at Innoviva Specialty Therapeutics, Inc. is responsible for overseeing the planning, execution, and management of clinical trials and research studies. This team collaborates with internal stakeholders and external partners to ensure the effective development and testing of investigational therapies for critical care and infectious diseases. They are integral in ensuring the quality, compliance, and scientific validity of clinical data to support regulatory submissions and the advancement of new treatments for drug-resistant pathogens.

Clinical Operations & Development

Director Team

Critical Care Team

Clinical Operations & Development

About

Team members

Other teams at Innoviva Specialty Therapeutics, Inc.

Director Team

Critical Care Team